Meso
Aftermath
Archived
Biotech resurgence: M&A activityand market performance
Aktivitas menurun — narasi kehilangan relevansi.
Skor
0,3
Kecepatan
▲ 0,0
Artikel
13
Sumber
2
Linimasa Sentimen
Performa Sektor
Kinerja Saham
Linimasa Peristiwa
Artikel Terkait
This Biotech Was Quietly Bought Before a $58 Per Share Takeout
Yahoo Finance
·
Mar 21, 2026
This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year
Nasdaq
·
Mar 20, 2026
My Top 3 Drug Stocks for March 2026
Nasdaq
·
Mar 20, 2026
Why biotech is back: IBT portfolio manager’s view
Yahoo Finance
·
Mar 20, 2026